BlackRock Institutional Trust’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

BlackRock Institutional Trust’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.77M	Buy	185,629 +6,097	+3%	+$85.6K	﹤0.01%	2945
2016 Q3	$2.25M	Buy	179,532 +613	+0.3%	+$6.15K	﹤0.01%	3004
2016 Q2	$1.61M	Buy	178,919 +10,948	+7%	+$107K	﹤0.01%	3120
2016 Q1	$1.67M	Sell	167,971 -4,492	-3%	-$46.1K	﹤0.01%	3117
2015 Q4	$1.98M	Buy	172,463 +3,592	+2%	+$44.4K	﹤0.01%	3127
2015 Q3	$2.28M	Buy	168,871 +23,016	+16%	+$312K	﹤0.01%	3074
2015 Q2	$2.02M	Buy	145,855 +7,900	+6%	+$107K	﹤0.01%	3117
2015 Q1	$1.94M	Buy	137,955 +29,398	+27%	+$400K	﹤0.01%	3124
2014 Q4	$1.48M	Sell	108,557 -3,946	-4%	-$53.9K	﹤0.01%	3237
2014 Q3	$1.72M	Sell	112,503 -26,216	-19%	-$402K	﹤0.01%	3143
2014 Q2	$2.33M	Buy	138,719 +77,244	+126%	+$1.39M	﹤0.01%	3124
2014 Q1	$1.23M	Buy	61,475 +2,764	+5%	+$59.8K	﹤0.01%	3345
2013 Q4	$1.14M	Buy	+58,711	New	+$1.04M	﹤0.01%	3358

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

BlackRock Institutional Trust's OXFD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Oxford Immunotec Global PLC Ordinary Shares (OXFD) stake by 3.4% in Q4 2016, buying an estimated $85.6K and bringing the position to 185,629 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2945.

BlackRock Institutional Trust first reported a position in OXFD in Q4 2013 and has held it in 13 quarters since. 73 funds tracked by Wall St. Rank hold OXFD as of Q4 2016.

BlackRock Institutional Trust held 185,629 shares of Oxford Immunotec Global PLC Ordinary Shares worth $2.77M as of Q4 2016.
BlackRock Institutional Trust bought 6,097 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2016, an estimated $85.6K.
Oxford Immunotec Global PLC Ordinary Shares made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2945 holding.
BlackRock Institutional Trust first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 13 quarters since.
73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.